Evidence map›Paper›PMID 32933132›Full record

ArticleVaccines2020

Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1.

Marcel Thalen, Anne-Sophie Debrie, Loic Coutte, Dominique Raze, Ken Solovay, Keith Rubin, Nathalie Mielcarek, Camille Locht

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Pertussis before, during and after Covid-19.EMBO molecular medicine · 2025
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marcel ThalenILiAD Biotechnologies, New York, NY 10003, USA.
Anne-Sophie DebrieCentre d'Infection et d'Immunité de Lille, Univ. Lille, CNRS, Inserm, CHU Lille, Institute Pasteur de Lille, U1019-UMR9017-CIIL-Center for Infection and Immunity of Lille, F-59000 Lille, France.
Loic CoutteCentre d'Infection et d'Immunité de Lille, Univ. Lille, CNRS, Inserm, CHU Lille, Institute Pasteur de Lille, U1019-UMR9017-CIIL-Center for Infection and Immunity of Lille, F-59000 Lille, France.ORCID 0000-0002-8626-8109
Dominique RazeCentre d'Infection et d'Immunité de Lille, Univ. Lille, CNRS, Inserm, CHU Lille, Institute Pasteur de Lille, U1019-UMR9017-CIIL-Center for Infection and Immunity of Lille, F-59000 Lille, France.ORCID 0000-0001-5836-063X
Ken SolovayILiAD Biotechnologies, New York, NY 10003, USA.
Keith RubinILiAD Biotechnologies, New York, NY 10003, USA.
Nathalie MielcarekCentre d'Infection et d'Immunité de Lille, Univ. Lille, CNRS, Inserm, CHU Lille, Institute Pasteur de Lille, U1019-UMR9017-CIIL-Center for Infection and Immunity of Lille, F-59000 Lille, France.
Camille LochtCentre d'Infection et d'Immunité de Lille, Univ. Lille, CNRS, Inserm, CHU Lille, Institute Pasteur de Lille, U1019-UMR9017-CIIL-Center for Infection and Immunity of Lille, F-59000 Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current pertussis vaccines protect against disease, but not against colonization by and transmission of

Indexed as

live attenuated vaccinelyophilizationpertussisvaccine stability

Identifiers

PMID32933132
PMCPMC7565209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.